Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    20609967 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid
2 Unknown  Carotid Atherosclerosis In Newly Diagnosed Type 2 Individuals
Condition: Type II Diabetes Mellitus Without Mention of Complication
Intervention: Other: Standard care
3 Completed Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Conditions: Diabetes Mellitus Type 2;   Metabolic Syndrome;   Cardiovascular Disease;   Diastolic Dysfunction;   Fatty Liver
Interventions: Drug: Liraglutide;   Drug: Liraglutide - Placebo

Indicates status has not been verified in more than two years